Skip directly to site content Skip directly to search


Here's how you know
 Official websites use .gov A .gov website belongs to an official government organization in the United States.
 Secure .gov websites use HTTPS A **lock** (  ) or **https://** means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


National Institute for Occupational Safety and Health (NIOSH)
 Explore Topics
 Search
	Clear Input
		Search


For Everyone
 About NIOSH
											Federal Register Notices
											Board of Scientific Counselors
											Events
											Contact
											Careers
											Training and Workforce Development
											Peer Review Agenda
											NIOSH eNews
																View all
 View All


search
                close search Clear Input
		search
 NIOSH Menu
            Close Clear Input
		search
 For Everyone
 About NIOSH
																							Federal Register Notices
																							Board of Scientific Counselors
																							Events
																							Contact
																							Careers
																							Training and Workforce Development
																							Peer Review Agenda
																						View All
																																				Home
 View All
						NIOSH


About NIOSH Federal Register Notices Board of Scientific Counselors Events Contact Careers Training and Workforce Development Peer Review Agenda View All




NIOSH
 Peer Review: A Vapor Containment Performance Protocol for CSTDs


At a glance
 NIOSH created a peer review plan for a vapor containment performance protocol for Closed System Drug-Transfer Devices (CSTDs). While CSTD performance standards are available that apply to sterile practice and patient protection, no CSTD performance standards are available for drug containment. To address this gap, NIOSH researchers are developing a test protocol that evaluates a CSTD's containment of hazardous drugs.
 Overview Updates‎ Closed System Drug-Transfer Device (CSTD) Research
 **Title:** A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs **Anticipated Date of Dissemination:** March 2023 **Subject:** Test protocol for evaluating the combined liquid, aerosol, and vapor containment performance of CSTDs in which a physical barrier prevents all drug mass from crossing the system boundary **Purpose:** Use by manufacturers and their customers to conduct meaningful comparisons between CSTD products **Timing of Review:** December 2014-January 2015 **Primary Disciplines or Expertise Needed for Review:** Industrial hygiene, occupational and environmental medicine, engineering, oncology, clinical practices **Type of Review:** Panel **Number of Reviewers:** 3 **Reviewers Selected by:** NIOSH **Public Nominations Requested for Review Panel:** Yes, 09/08/2015 **Opportunities for the Public to Comment:** None **Peer Reviewers Provided with Public Comments Before Their Review:** No
 Charge to peer reviewers Closed-system transfer devices (CSTD) have been shown to be an effective way to reduce surface contamination during the handling of hazardous drugs in the healthcare setting. This proposed protocol is not testing whether CSTDs are effective in reducing environmental contamination, but rather it is testing the closed-system performance of devices that claim to operate as closed systems. Thus, it tests a device's ability to meet the definition of not allowing the transfer of mass (liquid, particulate or vapor) in/out of the system. Several key decisions were made in the development of this protocol and we would like specific comment on these matters. Reviewers should evaluate the document for completeness, to identify gaps and issues or concerns, and to assess whether the document is written in a clear and understandable manner. In addition, specific questions about the protocol are given below. Isopropyl alcohol was used as a challenge agent to test the closed-system performance of the CSTDs. This selection was based on a number of factors including its liquid state when contained at room temperature, its high vapor pressure, and its ease of detection using common direct-reading instruments. Is isopropyl alcohol an appropriate challenge agent for the closed system containment test? If not, is there another challenge agent that should be considered to test the containment performance of CSTDs? Hazardous drugs have very different molecular structure and formulations, are unsafe, and limited measurement methods are available. Should drug formulations be considered challenge agents to test the performance of CSTDs?
Several pharmacy manipulation procedures are specified for use during the conduct of the CSTD containment test protocol. Do these procedures appear adequate for the intent of the protocol? Should any of the procedures be removed or additional procedures added?
NIOSH used the proposed CSTD containment test protocol to evaluate five CSTDs. In this evaluation, since a leakage of true zero cannot be measured, a limit of 1 ppm was identified to determine acceptable containment performance. This limit was based on a manipulation of the limit of detection of the instrument used to measure the isopropyl alcohol concentration. Was the NIOSH evaluation an appropriate use for the containment test protocol? Is it helpful to have the evaluation discussion in the protocol document? Was the selection of the 1.0 ppm performance threshold appropriate for this evaluation, given the instrumentation and measurement data?
Is the use of the factor (3.3) x the limit of detection that NIOSH uses in development of analytical methods appropriate in this instance for determination of the containment performance threshold? Are there other methods that should be considered to set a performance threshold?
Currently, the containment test protocol itself does not include a recommended performance threshold. Would the protocol be more useful if a performance threshold was recommended?
 Peer reviewers Nurtan A. Esmen, PhD
 University of Illinois at ChicagoAreas of expertise: chemical and air engineering, industrial hygiene, occupational and environmental medicine
 Martha Polovich, PhD, RN, AOCN
 Georgia State UniversityAreas of expertise: oncology, clinical practice, nursing research and education, safe handling of hazardous drugs
 Melissa A. McDiarmid, MD, MPH
 University of MarylandAreas of expertise: occupational and environmental medicine, oncology
 On This Page
	Overview
								Charge to peer reviewers
								Peer reviewers
  May 29, 2024 Sources Print Share
 Facebook LinkedIn Twitter Syndicate
 National Institute for Occupational Safety and Health


NIOSH National Institute for Occupational Safety and Health View All
 About NIOSH
													Federal Register Notices
													Board of Scientific Counselors
													Events
													Contact
 Careers
													Training and Workforce Development
													Peer Review Agenda
													NIOSH eNews
																			View All
 Sign up for Email Updates


Contact Us Contact Us Call 800-232-4636
							Contact CDC
 About CDC About CDC Mission & Organization
							Budget & Funding
							Careers & Jobs
 Policies Accessibility
									External Links
									Privacy
									Web Policies
 FOIA
									OIG
									No Fear Act
									Nondiscrimination
									Vulnerability Disclosure Policy
 Languages Languages Español
									Multilingual Content
 Language Assistance Español
											繁體中文
											Tiếng Việt
											한국어
 Tagalog
											Русский
											العربية
											Kreyòl Ayisyen
 Français
											Polski
											Português
											Italiano
 Deutsch
											日本語
											فارسی
											English
 Archive CDC Archive


Contact Us Contact Us  Call 800-232-4636
						Contact CDC
 About CDC Mission & Organization
						Budget & Funding
						Careers & Jobs
						About CDC
 Policies Accessibility
						External Links
						Privacy
						Web Policies FOIA
						OIG
						No Fear Act
						Nondiscrimination
						Vulnerability Disclosure Policy
 Languages Languages Español
						Multilingual Content Language Assistance Español
						繁體中文
						Tiếng Việt
						한국어
						Tagalog
						Русский
						العربية
						Kreyòl Ayisyen
						Français
						Polski
						Português
						Italiano
						Deutsch
						日本語
						فارسی
						English
 Archive CDC Archive





HHS.gov USA.gov